Study Focuses on Role of CDK12 Loss in Prostate Cancer
An orally administered CDK12/CDK13 degrader was found to slow down the destruction of cancerous cells, improving patient outcomes.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
An orally administered CDK12/CDK13 degrader was found to slow down the destruction of cancerous cells, improving patient outcomes.
Proactively addressing drug injection issues during treatment can help prevent relapse and fatalities.
This technique proved to be more effective than many other popular treatments.
Research reveals CD8 T cells’ role in early multiple sclerosis development.
Young adults shouldn’t be dismissive of unexplained symptoms.
When immunotherapy is administered can make a significant impact on a patient’s life expectancy.
Many studies have focused on determinants for asthma ER visits, but few have zeroed in on the racial disparities that exist.
Lack of resources and regulations, coupled with ease of access, have caused the country’s growing problem.
Umbilical cord blood transplants improve survival outcomes across all races and ethnicities, according to new research.
Inflammatory biomarkers found to be major contributors to the development of this type of cancer.